Workmat methodology for identifying drug choice factors

What did Adelphi Targis provide?

Our client, following the advent of the new oral anticoagulants on the market, asked us to come up with a project addressing experience in the use of the new oral anticoagulants (NOACs), defining the different patient profiles and reaching a consensus regarding the advantages of the NOACs over other alternatives.

A total of 39 specialists with extensive experience in anticoagulation took part in 6 regional meetings.

Physicians’ perception of the factors that impact the choice of a dicumarinic or a new oral anticoagulant in patients with nonvalvular atrial fibrillation.

Do you want to start up a project?

To top

C/ Aragó 182,  7th floor
08011 Barcelona - Spain
+34 93 452 39 11
This email address is being protected from spambots. You need JavaScript enabled to view it.